Research Working Group      Policy Development Working Group      International Affairs Working Group

Linking Researchers and Industry

  • The Avicenna Alliance is dedicated to ensuring the full innovation cycle of predictive medicine is represented.
  • The Virtual Physiological Human (VPH) Initiative, carries a non-diminishable 50% board representation on the Avicenna Alliance with Industry representatives from Medical Devices, Pharmaceuticals and Software also maintaining a 50% board membership.
  • The VPH Institute is a massive network of Research Organisations and Universities engaged in predictive or in silico medicine.
  • The VPH institute has its origins in a European Commission endorsed research area on computer modeling and simulation and has been active for over 10 years.
  • This partnership of industry and researchers allows the Avicenna Alliance to address challenges to the predictive or in silico market from pre-clinical research all the way to post-market. 

Avicenna Alliance news

EU and China cooperation dialogue for STI

On 9 April, the fourth Innovation Cooperation Dialogue, co-chaired by the European Commissioner for Research, Science and Innovation, Carlos Moedas and the...

find out more ›

Stryker joins the Avicenna Alliance

The Avicenna Alliance is proud to announce the newest addition to its list of members: Stryker. Stryker is one of the world’s leading medical technology companies...

find out more ›

FEops HEARTguideTM receives CE mark

The Avicenna Alliance Secretariat is proud to announce that one of its members, FEops, has received the ‘CE’ mark for its FEops HEARTguideTM.

The CE marking...

find out more ›

Show all activites